🇺🇸 FDA
Patent

US 8871191

Use of IL-15 preparations to treat lymphopenia

granted A61KA61K38/00A61K38/1793

Quick answer

US patent 8871191 (Use of IL-15 preparations to treat lymphopenia) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61K38/1793, A61K38/2086, A61K45/06